Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2017

View Archived Issues

Eisai reviews highlights of first quarter of fiscal 2017

Phase III study of Traumakine in ARDS recommended to continue

M Pharmaceutical USA changes name to Callitas Therapeutics

Ritter reports further analysis of phase IIb/III trial of RP-G28 for lactose intolerance

Lilly reports data from SPARTAN trial of lasmiditan for acute treatment of migraine

TCB selected to receive H2020 grant for the development of next-generation allogeneic approach

FDA grants priority review to Alecensa for first-line treatment of ALK-positive NSCLC

Mallinckrodt to acquire InfaCare along with its proprietary therapy stannsoporfin

MiMedx files to begin IND phase III trial of AmnioFix for achilles tendonitis

Ono Pharmaceutical updates milestones of first quarter of fiscal 2017

FDA issues complete response letter for CCP-08 NDA

Sanofi compound SAR-489883 targets protein kinase R for Alzheimer's disease

FDA grants orphan drug designation to OMS-721 for IgA nephropathy

UCB and Medical Research Council establish antibody discovery collaboration

HitGen and Leo Pharma establish multi-year research collaboration

Monoclonal IgM targets beta-amyloid and tau oligomers in Alzheimer's disease

The PS externalization pathway as a potential new target for the development of anti-HIV-1 therapies

New phase I trial studies MK-1092 in healthy subjects and patients with type 1 diabetes

Targeting HDAC6 as a potential new therapeutic strategy for ARID1A-mutated ovarian cancers

Biofrontera agrees to Ameluz development plan with FDA

Ningbo Wenda describes novel bromodomain-containing protein 4 inhibitors

Starpharma reports phase III results for VivaGel BV in recurrent bacterial vaginosis

Boehringer Ingelheim patents nuclear receptor RORgamma antagonists

Janssen R&D Ireland presents novel anti-influenza compounds

Prospero Pharmaceuticals divulges agents for pantothenate kinase-associated neurodegeneration

Clearance for first-in-human study of ORBCEL-M for diabetic kidney disease

Fred Hutchinson studies 211At-BC8-B10 before donor stem cell transplant in AML, ALL and MDS

EMO Biomedicine begins phase I study of RegStem for knee osteoarthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...